Cullinan Therapeutics, Inc. (CGEM) vs IRadimed Corporation (IRMD)
A side-by-side comparison of Cullinan Therapeutics, Inc. and IRadimed Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEM
Cullinan Therapeutics, Inc.
$17.16HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
IRMD
IRadimed Corporation
$85.04HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — CGEM vs IRMD
growth of $100 · dividends reinvested · last 6yCGEM -46.4% (-9.9%/yr)IRMD +305.8% (+26.3%/yr)IRMD compounded faster over this window
Log scale — wide-divergence pair
CGEM IRMD
CGEM vs IRMD: by the numbers
- •IRMD is the larger company ($1.09B vs $1.05B market cap).
- •IRMD is profitable (26.70% net margin) while CGEM runs a net loss (0.00%).
- •IRMD pays a dividend (1.47% yield), while CGEM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CGEM | IRMD |
|---|---|---|
| P/E ratio | N/A | 47.51 |
| Forward P/E | N/A | 40.24 |
| PEG ratio | N/A | 0.64 |
| P/S ratio | N/A | 12.59 |
| P/B ratio | 3.28 | 10.68 |
| EV / EBITDA | N/A | 34.95 |
| FCF yield | N/A | 2.29% |
Profitability
| Metric | CGEM | IRMD |
|---|---|---|
| Gross margin | 0.00% | 75.86% |
| Operating margin | 0.00% | 31.92% |
| Net margin | 0.00% | 26.70% |
| ROE | -63.62% | 22.66% |
| ROIC | -68.64% | 20.18% |
Dividends
| Metric | CGEM | IRMD |
|---|---|---|
| Dividend yield | N/A | 1.47% |
| Payout ratio | N/A | 70.95% |
Growth (annualized)
| Metric | CGEM | IRMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 19.60% |
| EPS CAGR (5Y) | N/A | 74.32% |
| FCF CAGR (5Y) | N/A | 26.20% |
| Total return CAGR (5Y) | -7.48% | 24.06% |
Frequently asked
- Does CGEM or IRMD pay a bigger dividend?
- IRMD pays a dividend (1.47% yield), while CGEM has no payments in the available dividend history.
- Is CGEM or IRMD more profitable?
- IRMD runs the higher net margin — CGEM at 0.00% versus IRMD at 26.70%.
- How have CGEM and IRMD total returns compared?
- Over the past 5 years, CGEM delivered -7.48% and IRMD delivered 24.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
IRadimed P/E ratioIRadimed dividend yieldCullinan Therapeutics ROEIRadimed ROECullinan Therapeutics operating marginIRadimed operating marginCullinan Therapeutics revenue growthIRadimed revenue growthCullinan Therapeutics free cash flowIRadimed free cash flow
Cullinan Therapeutics & IRadimed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.